Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Hyperlipoproteinemias

  Free Subscription


Articles published in Circulation

Retrieve available abstracts of 51 articles:
HTML format
Text format



Single Articles


    May 2018
  1. XIANG R, Fan LL, Huang H, Chen YQ, et al
    Increased RTN3 Leads to Obesity and Hypertriglyceridemia by Interacting with HSPA5.
    Circulation. 2018 May 1. pii: CIRCULATIONAHA.117.030718.
    PubMed     Text format     Abstract available


    March 2018
  2. BEHESHTI S, Madsen CM, Varbo A, Benn M, et al
    Relationship of Familial Hypercholesterolemia and High LDL Cholesterol to Ischemic Stroke: The Copenhagen General Population Study.
    Circulation. 2018 Mar 28. pii: CIRCULATIONAHA.118.033470.
    PubMed     Text format     Abstract available


  3. BUCHOLZ EM, Rodday AM, Kolor K, Khoury MJ, et al
    Prevalence and Predictors of Cholesterol Screening, Awareness, and Statin Treatment Among US Adults With Familial Hypercholesterolemia or Other Forms of Severe Dyslipidemia (1999-2014).
    Circulation. 2018 Mar 26. pii: CIRCULATIONAHA.117.032321.
    PubMed     Text format     Abstract available


    February 2018
  4. KUSTERS DM, Braamskamp MJAM, Langslet G, McCrindle BW, et al
    Response by Kusters et al to Letter Regarding Article, "Effect of Rosuvastatin on Carotid Intima-Media Thickness in Children With Heterozygous Familial Hypercholesterolemia: The CHARON Study (Hypercholesterolemia in Children and Adolescents Taking Ros
    Circulation. 2018;137:641-642.
    PubMed     Text format    


  5. KOH KK
    Letter by Koh Regarding Article, "Effect of Rosuvastatin on Carotid Intima-Media Thickness in Children With Heterozygous Familial Hypercholesterolemia: The CHARON Study (Hypercholesterolemia in Children and Adolescents Taking Rosuvastatin Open Label)"
    Circulation. 2018;137:639-640.
    PubMed     Text format    


    December 2017
  6. HESS GP, Natarajan P, Faridi KF, Fievitz A, et al
    Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor Therapy: Payer Approvals and Rejections, and Patient Characteristics for Successful Prescribing.
    Circulation. 2017;136:2210-2219.
    PubMed     Text format     Abstract available


    November 2017
  7. PEREZ DE ISLA L, Saltijeral Cerezo A, Mata P
    Response by Perez de Isla et al to Letter Regarding Article, "Predicting Cardiovascular Events in Familial Hypercholesterolemia: The SAFEHEART Registry (Spanish Familial Hypercholesterolemia Cohort Study)".
    Circulation. 2017;136:1984.
    PubMed     Text format    


  8. NATALE F, Di Maio M, Calabro P
    Letter by Natale et al Regarding Article, "Predicting Cardiovascular Events in Familial Hypercholesterolemia: The SAFEHEART Registry (Spanish Familial Hypercholesterolemia Cohort Study)".
    Circulation. 2017;136:1982-1983.
    PubMed     Text format    


    September 2017
  9. VALLEJO-VAZ AJ, Robertson M, Catapano AL, Watts GF, et al
    LDL-Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men with Primary Elevations of LDL-Cholesterol Levels of 190 mg/dL or Above: Analyses from the WOSCOPS 5-year Randomised Trial and 20-year Observational Follow-Up.
    Circulation. 2017 Sep 6. pii: CIRCULATIONAHA.117.027966.
    PubMed     Text format     Abstract available


    August 2017
  10. DROUIN-CHARTIER JP, Tremblay AJ, Bergeron J, Lamarche B, et al
    The Low-Density Lipoprotein Receptor Genotype Is a Significant Determinant of the Rebound in Low-Density Lipoprotein Cholesterol Concentration After Lipoprotein Apheresis Among Patients With Homozygous Familial Hypercholesterolemia.
    Circulation. 2017;136:880-882.
    PubMed     Text format    


  11. TONTONOZ P, Wu X, Jones M, Zhang Z, et al
    Long Noncoding RNA Facilitated Gene Therapy Reduces Atherosclerosis in a Murine Model of Familial Hypercholesterolemia.
    Circulation. 2017;136:776-778.
    PubMed     Text format    


    July 2017
  12. BLOM DJ, Averna MR, Meagher EA, du Toit Theron H, et al
    Long-Term Efficacy and Safety of the Microsomal Triglyceride Transfer Protein Inhibitor Lomitapide in Patients With Homozygous Familial Hypercholesterolemia.
    Circulation. 2017;136:332-335.
    PubMed     Text format    


  13. LERMAN JB, Joshi AA, Chaturvedi A, Aberra TM, et al
    Coronary Plaque Characterization in Psoriasis Reveals High-Risk Features That Improve After Treatment in a Prospective Observational Study.
    Circulation. 2017;136:263-276.
    PubMed     Text format     Abstract available


    June 2017
  14. BRAAMSKAMP MJAM, Langslet G, McCrindle BW, Cassiman DM, et al
    Effect of Rosuvastatin on Carotid Intima-Media Thickness in Children with Heterozygous Familial Hypercholesterolemia: The CHARON Study.
    Circulation. 2017 Jun 7. pii: CIRCULATIONAHA.116.025158.
    PubMed     Text format     Abstract available


    March 2017
  15. PEREZ DE ISLA L, Alonso R, Mata N, Fernandez-Perez C, et al
    Predicting Cardiovascular Events in Familial Hypercholesterolemia: The SAFEHEART Registry.
    Circulation. 2017 Mar 8. pii: CIRCULATIONAHA.116.024541.
    PubMed     Text format     Abstract available


    November 2016
  16. MAHMOODI BK, Cushman M, Naess IA, Allison MA, et al
    Association of Traditional Cardiovascular Risk Factors with Venous Thromboembolism: An Individual Participant Data Meta-analysis of Prospective Studies.
    Circulation. 2016 Nov 9. pii: CIRCULATIONAHA.116.024507.
    PubMed     Text format     Abstract available


  17. DE FERRANTI S, Sheldrick RC, Wong JB
    Response by de Ferranti et al to Letter Regarding Article, "Prevalence of Familial Hypercholesterolemia in the 1999 to 2012 United States National Health and Nutrition Examination Surveys (NHANES)".
    Circulation. 2016;134:e395-e396.
    PubMed     Text format    


  18. PEREZ DE ISLA L, Saltijeral Cerezo A, Mata P
    Letter by Perez de Isla et al Regarding Article, "Prevalence of Familial Hypercholesterolemia in the 1999 to 2012 United States National Health and Nutrition Examination Surveys (NHANES)".
    Circulation. 2016;134:e393-e394.
    PubMed     Text format    


    October 2016
  19. BOZKURT B, Aguilar D, Deswal A, Dunbar SB, et al
    Contributory Risk and Management of Comorbidities of Hypertension, Obesity, Diabetes Mellitus, Hyperlipidemia, and Metabolic Syndrome in Chronic Heart Failure: A Scientific Statement From the American Heart Association.
    Circulation. 2016 Oct 31. pii: CIR.0000000000000450.
    PubMed     Text format    


    September 2016
  20. HOVINGH GK, Kastelein JJ
    Diagnosis and Management of Individuals With Heterozygous Familial Hypercholesterolemia: Too Late and Too Little.
    Circulation. 2016;134:710-2.
    PubMed     Text format    


    July 2016
  21. NANCHEN D, Gencer B, Muller O, Auer R, et al
    Prognosis of Patients with Familial Hypercholesterolemia After Acute Coronary Syndromes.
    Circulation. 2016 Jul 26. pii: CIRCULATIONAHA.116.023007.
    PubMed     Text format     Abstract available


  22. TANG SY, Monslow J, R Grant G, Todd L, et al
    Cardiovascular Consequences of Prostanoid I Receptor Deletion in Microsomal Prostaglandin E Synthase-1-Deficient Hyperlipidemic Mice.
    Circulation. 2016;134:328-38.
    PubMed     Text format     Abstract available


  23. CHOMISTEK AK, Henschel B, Eliassen AH, Mukamal KJ, et al
    Frequency, Type, and Volume of Leisure-Time Physical Activity and Risk of Coronary Heart Disease in Young Women.
    Circulation. 2016;134:290-9.
    PubMed     Text format     Abstract available


  24. PATON DM
    Letter by Paton Regarding Article, "Knowing the Prevalence of Familial Hypercholesterolemia Matters".
    Circulation. 2016;134:e17-8.
    PubMed     Text format    


  25. HAAS ME, Levenson AE, Sun X, Liao WH, et al
    The Role of Proprotein Convertase Subtilisin/Kexin Type 9 in Nephrotic Syndrome-Associated Hypercholesterolemia.
    Circulation. 2016;134:61-72.
    PubMed     Text format     Abstract available


  26. PERAK AM, Ning H, de Ferranti SD, Gooding HC, et al
    Long-Term Risk of Atherosclerotic Cardiovascular Disease in US Adults With the Familial Hypercholesterolemia Phenotype.
    Circulation. 2016;134:9-19.
    PubMed     Text format     Abstract available


  27. RODRIGUEZ F, Knowles JW
    Enough Evidence, Time to Act!
    Circulation. 2016;134:20-3.
    PubMed     Text format    


    April 2016
  28. ONORATO A, Sturm AC
    Heterozygous Familial Hypercholesterolemia.
    Circulation. 2016;133:e587-9.
    PubMed     Text format    


    March 2016
  29. DE FERRANTI SD, Rodday AM, Mendelson MM, Wong JB, et al
    Prevalence of Familial Hypercholesterolemia in the 1999 to 2012 United States National Health and Nutrition Examination Surveys (NHANES).
    Circulation. 2016;133:1067-72.
    PubMed     Text format     Abstract available


  30. GOLDBERG AC, Gidding SS
    Knowing the Prevalence of Familial Hypercholesterolemia Matters.
    Circulation. 2016;133:1054-7.
    PubMed     Text format    


  31. KOENE RJ, Prizment AE, Blaes A, Konety SH, et al
    Shared Risk Factors in Cardiovascular Disease and Cancer.
    Circulation. 2016;133:1104-14.
    PubMed     Text format     Abstract available


  32. FORD I, Murray H, McCowan C, Packard CJ, et al
    Long-Term Safety and Efficacy of Lowering Low-Density Lipoprotein Cholesterol With Statin Therapy: 20-Year Follow-Up of West of Scotland Coronary Prevention Study.
    Circulation. 2016;133:1073-80.
    PubMed     Text format     Abstract available


    November 2015
  33. GUAN J, Khambhati J, Jones LW, Morgans A, et al
    Cardiology Patient Page. ABCDE Steps for Heart and Vascular Wellness Following a Prostate Cancer Diagnosis.
    Circulation. 2015;132:e218-20.
    PubMed     Text format    


    October 2015
  34. GIDDING SS, Ann Champagne M, de Ferranti SD, Defesche J, et al
    The Agenda for Familial Hypercholesterolemia: A Scientific Statement From the American Heart Association.
    Circulation. 2015 Oct 28. pii: CIR.0000000000000297.
    PubMed     Text format    


  35. DHANESHA N, Ahmad A, Prakash P, Doddapattar P, et al
    Genetic Ablation of Extra Domain A of Fibronectin in Hypercholesterolemic Mice Improves Stroke Outcome by Reducing Thrombo-Inflammation.
    Circulation. 2015 Oct 27. pii: CIRCULATIONAHA.115.016540.
    PubMed     Text format     Abstract available


  36. BERGERON N, Phan BA, Ding Y, Fong A, et al
    Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition: A New Therapeutic Mechanism for Reducing Cardiovascular Disease Risk.
    Circulation. 2015;132:1648-66.
    PubMed     Text format     Abstract available


  37. KIM JB, Kim K, Lindsay ME, MacGillivray T, et al
    Risk of rupture or dissection in descending thoracic aortic aneurysm.
    Circulation. 2015;132:1620-9.
    PubMed     Text format     Abstract available


  38. MESSINA LM
    Toward a Biologic Therapy to Improve Stroke Outcomes After Thrombolytic Therapy.
    Circulation. 2015 Oct 27. pii: CIRCULATIONAHA.115.019446.
    PubMed     Text format     Abstract available


  39. NAVAR-BOGGAN AM, Peterson ED, D'Agostino RB Sr, Neely B, et al
    Response to Letter Regarding Article, "Hyperlipidemia in Early Adulthood Increases Long-Term Risk of Coronary Heart Disease".
    Circulation. 2015;132:e203.
    PubMed     Text format    


  40. HAYWARD RA
    Letter by Hayward Regarding Article, "Hyperlipidemia in Early Adulthood Increases Long-Term Risk of Coronary Heart Disease".
    Circulation. 2015;132:e202.
    PubMed     Text format    


    September 2015
  41. WHITE JR, Chang CH, So-Armah KA, Stewart JC, et al
    Depression and HIV Infection are Risk Factors for Incident Heart Failure Among Veterans: Veterans Aging Cohort Study.
    Circulation. 2015 Sep 10. pii: CIRCULATIONAHA.114.014443.
    PubMed     Text format     Abstract available


    August 2015
  42. ABRAHAM TM, Pedley A, Massaro JM, Hoffman U, et al
    Association Between Visceral and Subcutaneous Adipose Depots and Incident Cardiovascular Disease Risk Factors.
    Circulation. 2015 Aug 20. pii: CIRCULATIONAHA.114.015000.
    PubMed     Text format     Abstract available


    July 2015
  43. PEDRIGI RM, Poulsen CB, Mehta VV, Holm NR, et al
    Inducing Persistent Flow Disturbances Accelerates Atherogenesis and Promotes Thin Cap Fibroatheroma Development in D374Y-PCSK9 Hypercholesterolemic Minipigs.
    Circulation. 2015 Jul 15. pii: CIRCULATIONAHA.115.016270.
    PubMed     Text format     Abstract available


    June 2015
  44. CHANG CH, Lin CH, Caffrey JL, Lee YC, et al
    Risk of Intracranial Hemorrhage From Statin Use in Asians: A Nationwide Cohort Study.
    Circulation. 2015;131:2070-8.
    PubMed     Text format     Abstract available


    May 2015
  45. LIN Z, Pan X, Wu F, Ye D, et al
    Fibroblast growth factor 21 prevents atherosclerosis by suppression of hepatic sterol regulatory element-binding protein-2 and induction of adiponectin in mice.
    Circulation. 2015;131:1861-71.
    PubMed     Text format     Abstract available


  46. KASAMATSU A, Takaya T, Mori S, Kashio K, et al
    Reconstruction of an extracardiac aortocoronary collateral and simulation of selective angiography with multidetector-row computed tomography.
    Circulation. 2015;131:e476-9.
    PubMed     Text format    


  47. FOX CS, Hall JL, Arnett DK, Ashley EA, et al
    Future translational applications from the contemporary genomics era: a scientific statement from the American Heart Association.
    Circulation. 2015;131:1715-36.
    PubMed     Text format     Abstract available


  48. RASHID S, Tavori H, Brown PE, Linton MF, et al
    Response to letter regarding article, "Proprotein convertase subtilisin kexin type 9 promotes intestinal overproduction of triglyceride-rich apolipoprotein B lipoproteins through both low-density lipoprotein receptor-dependent and -independent mechani
    Circulation. 2015;131:e428.
    PubMed     Text format    


  49. LE MAY C, Cariou B
    Letter from Le May and Cariou regarding article, "Proprotein convertase subtilisin kexin type 9 promotes intestinal overproduction of triglyceride-rich apolipoprotein B lipoproteins through both low-density lipoprotein receptor-dependent and -independ
    Circulation. 2015;131:e427.
    PubMed     Text format    


    March 2015
  50. FITCHETT DH, Hegele RA, Verma S
    Cardiology patient page. Statin intolerance.
    Circulation. 2015;131:e389-91.
    PubMed     Text format    


  51. BAUER RC, Tohyama J, Cui J, Cheng L, et al
    Knockout of Adamts7, a novel coronary artery disease locus in humans, reduces atherosclerosis in mice.
    Circulation. 2015;131:1202-13.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hyperlipoproteinemias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: